{"entity":{"type":"insider","cik":"0001405637","url":"/insider/0001405637","json_url":"/insider/0001405637.json","name":"REED VICKIE S","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":6,"n_filings":4,"first":"2021-01-08","last":"2022-01-18","span_basis":"filed_date"},"name_variants":[{"name":"REED VICKIE S","source":"filing","n_filings":4,"first_seen":"2021-01-08","last_seen":"2022-01-18"}],"transactions":[{"id":6663697,"accession":"0001214659-22-000858","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001214659-22-000858","line_url":"/filing/0001214659-22-000858#line-2","is_derivative":false,"issuer_cik":"0001405637","issuer_name":"Mirati Therapeutics, Inc.","issuer_ticker":"MRTX","issuer_name_source":null,"issuer_url":"/issuer/0001405637","owner_cik":"0001405637","owner_name":"REED VICKIE S","owner_display_name":"REED VICKIE S","owner_url":"/insider/0001405637","role":"Officer (SVP, Chief Accounting Officer)","role_mark":"O","role_mark_label":"Officer (SVP, Chief Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Chief Accounting Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":533.0,"shares_display":"533","price_per_share":120.4826,"price_display":"120.48","price_state":"stated","total_value":64217.2258,"total_display":"64,217.23","total_whole":"64,217","shares_owned_after":15369.0,"shares_owned_after_display":"15,369","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-01-18","filed_date":"2022-01-18","scope":"insider"},{"id":6436110,"accession":"0001214659-22-000470","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001214659-22-000470","line_url":"/filing/0001214659-22-000470#line-1","is_derivative":false,"issuer_cik":"0001405637","issuer_name":"Mirati Therapeutics, Inc.","issuer_ticker":"MRTX","issuer_name_source":null,"issuer_url":"/issuer/0001405637","owner_cik":"0001405637","owner_name":"REED VICKIE S","owner_display_name":"REED VICKIE S","owner_url":"/insider/0001405637","role":"Officer (SVP, Chief Accounting Officer)","role_mark":"O","role_mark_label":"Officer (SVP, Chief Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Chief Accounting Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":345.0,"shares_display":"345","price_per_share":135.9419,"price_display":"135.94","price_state":"stated","total_value":46899.9555,"total_display":"46,899.96","total_whole":"46,900","shares_owned_after":10525.0,"shares_owned_after_display":"10,525","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-01-07","filed_date":"2022-01-07","scope":"insider"},{"id":6214272,"accession":"0001214659-22-000417","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001214659-22-000417","line_url":"/filing/0001214659-22-000417#line-1","is_derivative":false,"issuer_cik":"0001405637","issuer_name":"Mirati Therapeutics, Inc.","issuer_ticker":"MRTX","issuer_name_source":null,"issuer_url":"/issuer/0001405637","owner_cik":"0001405637","owner_name":"REED VICKIE S","owner_display_name":"REED VICKIE S","owner_url":"/insider/0001405637","role":"Officer (SVP, Chief Accounting Officer)","role_mark":"O","role_mark_label":"Officer (SVP, Chief Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Chief Accounting Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":758.0,"shares_display":"758","price_per_share":147.7395,"price_display":"147.74","price_state":"stated","total_value":111986.541,"total_display":"111,986.54","total_whole":"111,987","shares_owned_after":10870.0,"shares_owned_after_display":"10,870","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-01-04","filed_date":"2022-01-06","scope":"insider"},{"id":4905365,"accession":"0001214659-21-000341","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001214659-21-000341","line_url":"/filing/0001214659-21-000341#line-3","is_derivative":false,"issuer_cik":"0001405637","issuer_name":"Mirati Therapeutics, Inc.","issuer_ticker":"MRTX","issuer_name_source":null,"issuer_url":"/issuer/0001405637","owner_cik":"0001405637","owner_name":"REED VICKIE S","owner_display_name":"REED VICKIE S","owner_url":"/insider/0001405637","role":"Officer (SVP, Chief Accounting Officer)","role_mark":"O","role_mark_label":"Officer (SVP, Chief Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Chief Accounting Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":241.0,"shares_display":"241","price_per_share":216.3272,"price_display":"216.33","price_state":"stated","total_value":52134.8552,"total_display":"52,134.86","total_whole":"52,135","shares_owned_after":7471.0,"shares_owned_after_display":"7,471","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-07","filed_date":"2021-01-08","scope":"insider"},{"id":4905361,"accession":"0001214659-21-000341","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001214659-21-000341","line_url":"/filing/0001214659-21-000341","is_derivative":false,"issuer_cik":"0001405637","issuer_name":"Mirati Therapeutics, Inc.","issuer_ticker":"MRTX","issuer_name_source":null,"issuer_url":"/issuer/0001405637","owner_cik":"0001405637","owner_name":"REED VICKIE S","owner_display_name":"REED VICKIE S","owner_url":"/insider/0001405637","role":"Officer (SVP, Chief Accounting Officer)","role_mark":"O","role_mark_label":"Officer (SVP, Chief Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Chief Accounting Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":538.0,"shares_display":"538","price_per_share":210.39089144981412,"price_display":"210.39","price_state":"stated","total_value":113190.2996,"total_display":"113,190.30","total_whole":"113,190","shares_owned_after":7712.0,"shares_owned_after_display":"7,712","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-06","filed_date":"2021-01-08","scope":"insider","n_lines":2}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":6,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":6,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":6},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001576263","name":"Mirati Therapeutics, Inc.","url":"/issuer/0001576263","role":"Officer (SVP, Chief Accounting Officer)","n_filings":4,"first_seen":"2021-01-08","last_seen":"2022-01-18"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001405637","retrieved_at":"2026-08-25T14:54:59+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}